The company has posted net profit loss of Rs. 3.78 crores for the period ended December 31, 2019.
The company posted net profit loss of Rs.1.12 crores for the period ended December 31, 2019.
The company s posted net loss of Rs. 1.38 crores for the period ended December 31, 2019.
It posted net profit of Rs.9.28 crores for the period ended December 31, 2019.
The company posted net profit of Rs.683.94 crores for the period ended December 31, 2019.
The company posted net profit of Rs.25.37 crores for the period ended December 31, 2019.
Pfizer Limited (PFL) reported an operationally strong performance in the quarter. Revenue grew 10.3% YoY to Rs6.0bn (I-Sec: Rs6.0bn) as company is benefiting from its vitamins / minerals / nutrients (VMN) portfolio in the current environment. EBITDA margin jumped 840bps YoY to 33.2% (I-Sec: 29.8%) driven by lower S, G&A costs and adjusted PAT grew 25.2% YoY to Rs1.4bn.
The centralized marketing authorization granted by the EC is valid in all EU Member
The new facility further expands the company’s capacity and reinforces its leading supply position in Penang to serve the fast-growing customer demand from the electrical and electronics (E&E) and other manufacturing industries
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
.jpg)
The company's gas sales volume has shown a robust recovery post lockdown.
Among subsidiaries, Marpol and Perma grew in high double digits.
The medical device Sector in India suffers from a considerable cost of manufacturing disability.
The Cabinet Committee on Economic Affairs accorded approval to the proposal of the Department of Fertilizers for Grant-in-aid of Rs.100 crore to BVFCL
According to IQVIA sales data for the 12 month period ending December 2020, the Cleocin T Gel, 1% market achieved annual sales of approximately $73.8 million.
The company posted net profit of Rs.1.66 crores for the period ended December 31, 2019.
The company has posted net profit of Rs.33.02 crores for the 9 months period ended December 31, 2020.
Be One is a 100% Ayurvedic health and wellness supplement.
The award was presented to the Huntsman Textile Effects Baroda plant.
Sumitomo's EBITDA margin has steadily improved from 11.5% in FY18 to 17.2% in FY21E.
Subscribe to our newsletter & stay updated.
_195_291.jpg)
